Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-690514 vs Lapatinib with Letrozole in Advanced Breast Cancer
NCT01068704Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jun 2010
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of BMS-690514 in breast cancer, sponsored by Bristol Myers Squibb. Started Jun 2010; status: completed.
02
Drugs
BMS-690514
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01068704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01068704.